Cocrystal Pharma Inc - ESG Rating & Company Profile powered by AI
This report of Cocrystal Pharma Inc is prepared by All Street Sevva using leading Cognitive Robots. Alternative corporations in the scoring industry group for Cocrystal Pharma Inc are shown below. This analysis of Cocrystal Pharma Inc leverages data from across the internet and also from public documents by Cocrystal Pharma Inc.
Cocrystal Pharma Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.7; made up of an environmental score of 0.0, social score of 3.2 and governance score of 8.0.
3.7
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1112 | XSpray Pharma AB (publ) | 3.8 | Medium |
| 1112 | Zhongzhi Pharmaceutical Holdings Ltd | 3.8 | Medium |
| 1132 | Cocrystal Pharma Inc | 3.7 | Medium |
| 1132 | Chemometec A/S | 3.7 | Medium |
| 1132 | BEACON Pharmaceutical Ltd | 3.7 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Cocrystal Pharma Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Cocrystal Pharma Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Cocrystal Pharma Inc report the average age of the workforce?
Sign up for free to unlockDoes Cocrystal Pharma Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Cocrystal Pharma Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Cocrystal Pharma Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Cocrystal Pharma Inc offer flexible work?
Sign up for free to unlockDoes Cocrystal Pharma Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Cocrystal Pharma Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Cocrystal Pharma Inc conduct supply chain audits?
Sign up for free to unlockDoes Cocrystal Pharma Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Cocrystal Pharma Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Cocrystal Pharma Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Cocrystal Pharma Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Cocrystal Pharma Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Cocrystal Pharma Inc disclose water use targets?
Sign up for free to unlockDoes Cocrystal Pharma Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Cocrystal Pharma Inc have a product recall in the last two years?
Sign up for free to unlockDoes Cocrystal Pharma Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Cocrystal Pharma Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Cocrystal Pharma Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Cocrystal Pharma Inc disclose parental leave metrics?
Sign up for free to unlockDoes Cocrystal Pharma Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Cocrystal Pharma Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Cocrystal Pharma Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Cocrystal Pharma Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Cocrystal Pharma Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Cocrystal Pharma Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Cocrystal Pharma Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Cocrystal Pharma Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Cocrystal Pharma Inc disclose its waste policy?
Sign up for free to unlockDoes Cocrystal Pharma Inc report according to TCFD requirements?
Sign up for free to unlockDoes Cocrystal Pharma Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Cocrystal Pharma Inc disclose energy use targets?
Sign up for free to unlockDoes Cocrystal Pharma Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Cocrystal Pharma Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Cocrystal Pharma Inc
These potential risks are based on the size, segment and geographies of the company.
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that is in preclinical development trials for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections; and drug discovery collaboration with HitGen and InterX Inc. The company is headquartered in Bothell, Washington.